How can the workflow be revised so that the psychiatric‑mental health nurse practitioner (PMHNP) is responsible only for behavioral‑health medication management, while the therapist handles intake, opioid use disorder (OUD) screening, psychosocial assessment, counseling, and coordination of medication‑assisted treatment?

PMHNP-Focused Behavioral Health Medication Management Workflow

The PMHNP should function in a consultative medication management role while the therapist handles all intake, OUD screening, psychosocial assessment, counseling, and MAT coordination—this tiered model maximizes both providers' scope of practice and improves patient access to appropriate care levels 1, 2.

Workflow Structure

Therapist Responsibilities (Front-Line)

• Complete initial intake and comprehensive assessment including:

  • OUD screening using validated tools
  • Full psychosocial history
  • Mental health symptom assessment
  • Substance use history and current patterns
  • Social determinants of health
  • Risk assessment (suicide, overdose)

• Provide ongoing counseling using evidence-based modalities:

  • Motivational interviewing
  • Cognitive-behavioral therapy
  • Contingency management
  • Dialectical behavior therapy for complex cases 3

• Coordinate MAT services:

  • Facilitate referrals to buprenorphine or methadone programs
  • Monitor adherence and side effects
  • Provide psychosocial support for MAT patients
  • Connect patients to community resources

PMHNP Responsibilities (Consultative Medication Management)

Establish a tiered referral system where the therapist refers patients to the PMHNP based on medication complexity 1:

Tier 1 (Therapist manages with PMHNP consultation):

• Stable patients on established regimens
• Simple medication adjustments
• Routine monitoring

Tier 2 (PMHNP direct management):

• New medication initiations
• Complex polypharmacy
• Treatment-resistant conditions
• Significant side effects or drug interactions
• Co-occurring severe mental illness and substance use disorders
• Patients requiring MOUD prescribing (buprenorphine, naltrexone) 4, 5

Operational Flow

Initial Patient Contact

1. Therapist conducts intake (60-90 minutes)
2. Therapist determines medication need during assessment
3. Therapist assigns tier level based on complexity
4. Therapist initiates appropriate referral pathway

For Medication-Requiring Patients

Tier 2 patients receive PMHNP appointment within 1-2 weeks:

• PMHNP conducts focused psychiatric medication evaluation (30-45 minutes)
• PMHNP prescribes and provides medication education
• PMHNP establishes follow-up schedule based on medication type and stability
• PMHNP communicates plan back to therapist via shared EHR

Ongoing care coordination:

• Therapist continues weekly/biweekly counseling
• PMHNP sees patient monthly initially, then quarterly when stable
• Regular case reviews between PMHNP and therapist (weekly huddles recommended) 1
• Therapist monitors medication adherence, side effects, and response during therapy sessions
• Therapist alerts PMHNP to emerging concerns requiring medication adjustment

For OUD-Specific Patients

Critical workflow distinction: The therapist handles all MAT coordination but the PMHNP prescribes when indicated 4, 5:

1. Therapist screens for OUD during intake
2. Therapist provides psychosocial OUD counseling and harm reduction education
3. Therapist refers to PMHNP for MOUD evaluation if patient meets criteria for buprenorphine or naltrexone
4. PMHNP evaluates and prescribes MOUD if appropriate (buprenorphine for ages 16+, naltrexone for co-occurring alcohol use or unstable housing) 4
5. Therapist coordinates ongoing MAT services: monitors adherence, provides counseling, manages psychosocial barriers
6. PMHNP manages medication adjustments and monitors for diversion/misuse

For methadone: Therapist refers to specialized methadone clinic (federal regulations restrict most programs to age 18+) 4

Communication Infrastructure

Establish structured touchpoints to prevent siloed care 6:

• Weekly team huddles (15-30 minutes): Review new referrals, discuss complex cases, coordinate care plans
• Shared EHR documentation: Both providers document in unified care plan
• Warm handoffs when possible: Therapist introduces patient to PMHNP during first medication visit
• Standardized referral template: Includes tier assignment, medication history, current symptoms, psychosocial factors

Common Pitfalls to Avoid

Do not create parallel treatment silos where therapist and PMHNP work independently—this replicates the "coordinated care" model that research shows is least effective 6. The integrated model requires active collaboration.

Do not have PMHNP conduct full psychosocial assessments—this duplicates therapist work and wastes PMHNP capacity for medication management 1.

Do not restrict PMHNP access to only "severe" cases—many patients need both medication and therapy, and artificial barriers reduce treatment effectiveness 7.

Address stigma proactively: Both providers need education on MOUD benefits, as misconceptions persist even among behavioral health staff 8. MOUD is evidence-based treatment, not "replacing one drug with another."

Ensure adequate scheduling flexibility: Rigid appointment structures limit rapid access to medication evaluation, particularly for OUD patients who may be in acute withdrawal 7.

Scope Optimization

This model allows:

• Therapist to practice full scope: comprehensive assessment, evidence-based counseling, care coordination
• PMHNP to practice full scope: psychiatric consultation, complex medication management, MOUD prescribing
• Patients to receive appropriate level of care without unnecessary appointments 1

The consultative PMHNP role is well-supported in integrated behavioral health models and particularly effective in primary care and community health center settings 6, 2. This approach addresses workforce shortages by maximizing each provider's unique expertise rather than having the PMHNP duplicate services the therapist can provide 6.